Aamir, A., & Hafsa, H. (2025). DDL-920 mediated enhancement of γ-oscillations targeting γ-aminobutyric acid receptors: A novel therapeutic strategy to improve cognition in Alzheimer's disease. Iran University of Medical Sciences.
Chicago Style (17th ed.) CitationAamir, Ali, and Hafiza Hafsa. DDL-920 Mediated Enhancement of γ-oscillations Targeting γ-aminobutyric Acid Receptors: A Novel Therapeutic Strategy to Improve Cognition in Alzheimer's Disease. Iran University of Medical Sciences, 2025.
MLA (9th ed.) CitationAamir, Ali, and Hafiza Hafsa. DDL-920 Mediated Enhancement of γ-oscillations Targeting γ-aminobutyric Acid Receptors: A Novel Therapeutic Strategy to Improve Cognition in Alzheimer's Disease. Iran University of Medical Sciences, 2025.
Warning: These citations may not always be 100% accurate.